APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pyrazinamide

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pyrazinamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchPyrazinamide Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Pyrazinamide Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Pyrazinamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pyrazinamide Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pyrazinamide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Pyrazinamide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pyrazinamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pyrazinamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pyrazinamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pyrazinamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pyrazinamide include Beijing Ouhe Technology, Energy Chemical, Waterstone Technology, Toronto Research Chemicals, TCI, Pure Chemistry Scientific, Meryer (Shanghai) Chemical Technology, LGM Pharma and J & K SCIENTIFIC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pyrazinamide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pyrazinamide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pyrazinamide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pyrazinamide market size, projected growth trends, production technologies, key applications, and end-use industries.

Pyrazinamide Segment by Company

Beijing Ouhe Technology

Energy Chemical

Waterstone Technology

Toronto Research Chemicals

TCI

Pure Chemistry Scientific

Meryer (Shanghai) Chemical Technology

LGM Pharma

J & K SCIENTIFIC

HBCChem

EDQM

City Chemical

AlliChem

Alfa Chemistry

Acros Organics

Pyrazinamide Segment by Type

Purity 98%

Purity 99%

Others

Pyrazinamide Segment by Application

Children

Adult

Pyrazinamide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pyrazinamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pyrazinamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pyrazinamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pyrazinamide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pyrazinamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pyrazinamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pyrazinamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pyrazinamide Industry Trends Table 2. Pyrazinamide Industry Drivers Table 3. Pyrazinamide Industry Opportunities and Challenges Table 4. Pyrazinamide Industry Restraints Table 5. Global Pyrazinamide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pyrazinamide Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pyrazinamide Sales by Manufacturers (W Tons) & (2021-2026) Table 8. Global Pyrazinamide Sales Market Share by Manufacturers Table 9. Global Pyrazinamide Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Pyrazinamide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pyrazinamide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pyrazinamide Manufacturers, Product Type & Application Table 13. Global Pyrazinamide Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pyrazinamide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Purity 98% Table 17. Major Manufacturers of Purity 99% Table 18. Major Manufacturers of Others Table 19. Global Pyrazinamide Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 20. Global Pyrazinamide Sales by Type (2021-2026) & (W Tons) Table 21. Global Pyrazinamide Sales by Type (2027-2032) & (W Tons) Table 22. Global Pyrazinamide Sales Market Share by Type (2021-2026) Table 23. Global Pyrazinamide Sales Market Share by Type (2027-2032) Table 24. Global Pyrazinamide Revenue by Type 2021 VS 2025 VS 2032 (W Tons) Table 25. Global Pyrazinamide Revenue by Type (2021-2026) & (W Tons) Table 26. Global Pyrazinamide Revenue by Type (2027-2032) & (W Tons) Table 27. Global Pyrazinamide Revenue Market Share by Type (2021-2026) Table 28. Global Pyrazinamide Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Children Table 30. Major Manufacturers of Adult Table 31. Global Pyrazinamide Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 32. Global Pyrazinamide Sales by Application (2021-2026) & (W Tons) Table 33. Global Pyrazinamide Sales by Application (2027-2032) & (W Tons) Table 34. Global Pyrazinamide Sales Market Share by Application (2021-2026) Table 35. Global Pyrazinamide Sales Market Share by Application (2027-2032) Table 36. Global Pyrazinamide Revenue by Application 2021 VS 2025 VS 2032 (W Tons) Table 37. Global Pyrazinamide Revenue by Application (2021-2026) & (W Tons) Table 38. Global Pyrazinamide Revenue by Application (2027-2032) & (W Tons) Table 39. Global Pyrazinamide Revenue Market Share by Application (2021-2026) Table 40. Global Pyrazinamide Revenue Market Share by Application (2027-2032) Table 41. Global Pyrazinamide Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 42. Global Pyrazinamide Sales by Region (2021-2026) & (W Tons) Table 43. Global Pyrazinamide Sales Market Share by Region (2021-2026) Table 44. Global Pyrazinamide Sales Forecasted by Region (2027-2032) & (W Tons) Table 45. Global Pyrazinamide Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Pyrazinamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 47. North America Pyrazinamide Sales by Country (2021-2026) & (W Tons) Table 48. North America Pyrazinamide Sales by Country (2027-2032) & (W Tons) Table 49. Europe Pyrazinamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 50. Europe Pyrazinamide Sales by Country (2021-2026) & (W Tons) Table 51. Europe Pyrazinamide Sales by Country (2027-2032) & (W Tons) Table 52. Asia Pacific Pyrazinamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 53. Asia Pacific Pyrazinamide Sales by Country (2021-2026) & (W Tons) Table 54. Asia Pacific Pyrazinamide Sales by Country (2027-2032) & (W Tons) Table 55. South America, Middle East and Africa Pyrazinamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 56. South America, Middle East and Africa Pyrazinamide Sales by Country (2021-2026) & (W Tons) Table 57. South America, Middle East and Africa Pyrazinamide Sales by Country (2027-2032) & (W Tons) Table 58. Global Pyrazinamide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Pyrazinamide Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Pyrazinamide Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Pyrazinamide Revenue Market Share by Region (2021-2026) Table 62. Global Pyrazinamide Revenue Market Share by Region (2027-2032) Table 63. Beijing Ouhe Technology Company Information Table 64. Beijing Ouhe Technology Business Overview Table 65. Beijing Ouhe Technology Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Beijing Ouhe Technology Pyrazinamide Product Portfolio Table 67. Beijing Ouhe Technology Recent Development Table 68. Energy Chemical Company Information Table 69. Energy Chemical Business Overview Table 70. Energy Chemical Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Energy Chemical Pyrazinamide Product Portfolio Table 72. Energy Chemical Recent Development Table 73. Waterstone Technology Company Information Table 74. Waterstone Technology Business Overview Table 75. Waterstone Technology Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Waterstone Technology Pyrazinamide Product Portfolio Table 77. Waterstone Technology Recent Development Table 78. Toronto Research Chemicals Company Information Table 79. Toronto Research Chemicals Business Overview Table 80. Toronto Research Chemicals Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Toronto Research Chemicals Pyrazinamide Product Portfolio Table 82. Toronto Research Chemicals Recent Development Table 83. TCI Company Information Table 84. TCI Business Overview Table 85. TCI Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. TCI Pyrazinamide Product Portfolio Table 87. TCI Recent Development Table 88. Pure Chemistry Scientific Company Information Table 89. Pure Chemistry Scientific Business Overview Table 90. Pure Chemistry Scientific Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Pure Chemistry Scientific Pyrazinamide Product Portfolio Table 92. Pure Chemistry Scientific Recent Development Table 93. Meryer (Shanghai) Chemical Technology Company Information Table 94. Meryer (Shanghai) Chemical Technology Business Overview Table 95. Meryer (Shanghai) Chemical Technology Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Meryer (Shanghai) Chemical Technology Pyrazinamide Product Portfolio Table 97. Meryer (Shanghai) Chemical Technology Recent Development Table 98. LGM Pharma Company Information Table 99. LGM Pharma Business Overview Table 100. LGM Pharma Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. LGM Pharma Pyrazinamide Product Portfolio Table 102. LGM Pharma Recent Development Table 103. J & K SCIENTIFIC Company Information Table 104. J & K SCIENTIFIC Business Overview Table 105. J & K SCIENTIFIC Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. J & K SCIENTIFIC Pyrazinamide Product Portfolio Table 107. J & K SCIENTIFIC Recent Development Table 108. HBCChem Company Information Table 109. HBCChem Business Overview Table 110. HBCChem Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. HBCChem Pyrazinamide Product Portfolio Table 112. HBCChem Recent Development Table 113. EDQM Company Information Table 114. EDQM Business Overview Table 115. EDQM Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. EDQM Pyrazinamide Product Portfolio Table 117. EDQM Recent Development Table 118. City Chemical Company Information Table 119. City Chemical Business Overview Table 120. City Chemical Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. City Chemical Pyrazinamide Product Portfolio Table 122. City Chemical Recent Development Table 123. AlliChem Company Information Table 124. AlliChem Business Overview Table 125. AlliChem Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. AlliChem Pyrazinamide Product Portfolio Table 127. AlliChem Recent Development Table 128. Alfa Chemistry Company Information Table 129. Alfa Chemistry Business Overview Table 130. Alfa Chemistry Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Alfa Chemistry Pyrazinamide Product Portfolio Table 132. Alfa Chemistry Recent Development Table 133. Acros Organics Company Information Table 134. Acros Organics Business Overview Table 135. Acros Organics Pyrazinamide Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Acros Organics Pyrazinamide Product Portfolio Table 137. Acros Organics Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Pyrazinamide Distributors List Table 141. Pyrazinamide Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Pyrazinamide Product Image Figure 2. Global Pyrazinamide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pyrazinamide Market Size (2021-2032) & (US$ Million) Figure 4. Global Pyrazinamide Sales (2021-2032) & (W Tons) Figure 5. Global Pyrazinamide Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Pyrazinamide Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Purity 98% Image Figure 9. Purity 99% Image Figure 10. Others Image Figure 11. Global Pyrazinamide Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 12. Global Pyrazinamide Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Pyrazinamide Sales Market Share by Type (2021-2032) Figure 14. Global Pyrazinamide Revenue by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 15. Global Pyrazinamide Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Pyrazinamide Revenue Market Share by Type (2021-2032) Figure 17. Children Image Figure 18. Adult Image Figure 19. Global Pyrazinamide Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 20. Global Pyrazinamide Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Pyrazinamide Sales Market Share by Application (2021-2032) Figure 22. Global Pyrazinamide Revenue by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 23. Global Pyrazinamide Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Pyrazinamide Revenue Market Share by Application (2021-2032) Figure 25. North America Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 26. North America Pyrazinamide Sales Market Share by Country (2021-2032) Figure 27. U.S. Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 28. Canada Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 29. Mexico Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 30. Europe Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 31. Europe Pyrazinamide Sales Market Share by Country (2021-2032) Figure 32. Germany Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 33. France Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 34. U.K. Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 35. Italy Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 36. Netherlands Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 37. Asia Pacific Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 38. Asia Pacific Pyrazinamide Sales Market Share by Country (2021-2032) Figure 39. China Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 40. Japan Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 41. South Korea Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 42. Southeast Asia Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 43. India Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 44. Australia Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 45. South America, Middle East and Africa Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 46. South America, Middle East and Africa Pyrazinamide Sales Market Share by Country (2021-2032) Figure 47. Brazil Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 48. South Africa Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 49. Saudi Arabia Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 50. Turkey Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 51. Argentina Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 52. UAE Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 53. Egypt Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 54. Chile Pyrazinamide Sales and Growth Rate (2021-2032) & (W Tons) Figure 55. Global Pyrazinamide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Pyrazinamide Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Pyrazinamide Revenue (2021-2032) & (US$ Million) Figure 58. North America Pyrazinamide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Pyrazinamide Revenue (2021-2032) & (US$ Million) Figure 60. Europe Pyrazinamide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Pyrazinamide Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Pyrazinamide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Pyrazinamide Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Pyrazinamide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Pyrazinamide Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Pyrazinamide Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 98%
  • Purity 99%
  • Others
Applications
  • Children
  • Adult
Companies covered
  • Beijing Ouhe Technology
  • Energy Chemical
  • Waterstone Technology
  • Toronto Research Chemicals
  • TCI
  • Pure Chemistry Scientific
  • Meryer (Shanghai) Chemical Technology
  • LGM Pharma
  • J & K SCIENTIFIC
  • HBCChem
  • EDQM
  • City Chemical
  • AlliChem
  • Alfa Chemistry
  • Acros Organics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pyrazinamide Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pyrazinamide Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pyrazinamide Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pyrazinamide Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pyrazinamide Market Dynamics
  1. 2.1 Pyrazinamide Industry Trends
  2. 2.2 Pyrazinamide Industry Drivers
  3. 2.3 Pyrazinamide Industry Opportunities and Challenges
  4. 2.4 Pyrazinamide Industry Restraints
3 Pyrazinamide Market by Manufacturers
  1. 3.1 Global Pyrazinamide Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pyrazinamide Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pyrazinamide Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pyrazinamide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pyrazinamide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pyrazinamide Manufacturers, Product Type & Application
  7. 3.7 Global Pyrazinamide Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pyrazinamide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pyrazinamide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pyrazinamide Tier 1, Tier 2, and Tier 3
4 Pyrazinamide Market by Type
  1. 4.1 Pyrazinamide Type Introduction
  2. 4.1.1 Purity 98%
  3. 4.1.2 Purity 99%
  4. 4.1.3 Others
  5. 4.2 Global Pyrazinamide Sales by Type
  6. 4.2.1 Global Pyrazinamide Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pyrazinamide Sales by Type (2021-2032)
  8. 4.2.3 Global Pyrazinamide Sales Market Share by Type (2021-2032)
  9. 4.3 Global Pyrazinamide Revenue by Type
  10. 4.3.1 Global Pyrazinamide Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pyrazinamide Revenue by Type (2021-2032)
  12. 4.3.3 Global Pyrazinamide Revenue Market Share by Type (2021-2032)
5 Pyrazinamide Market by Application
  1. 5.1 Pyrazinamide Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Pyrazinamide Sales by Application
  5. 5.2.1 Global Pyrazinamide Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pyrazinamide Sales by Application (2021-2032)
  7. 5.2.3 Global Pyrazinamide Sales Market Share by Application (2021-2032)
  8. 5.3 Global Pyrazinamide Revenue by Application
  9. 5.3.1 Global Pyrazinamide Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pyrazinamide Revenue by Application (2021-2032)
  11. 5.3.3 Global Pyrazinamide Revenue Market Share by Application (2021-2032)
6 Global Pyrazinamide Sales by Region
  1. 6.1 Global Pyrazinamide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pyrazinamide Sales by Region (2021-2032)
  3. 6.2.1 Global Pyrazinamide Sales by Region (2021-2026)
  4. 6.2.2 Global Pyrazinamide Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pyrazinamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pyrazinamide Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pyrazinamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pyrazinamide Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pyrazinamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pyrazinamide Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pyrazinamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pyrazinamide Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pyrazinamide Revenue by Region
  1. 7.1 Global Pyrazinamide Revenue by Region
  2. 7.1.1 Global Pyrazinamide Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pyrazinamide Revenue by Region (2021-2026)
  4. 7.1.3 Global Pyrazinamide Revenue by Region (2027-2032)
  5. 7.1.4 Global Pyrazinamide Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pyrazinamide Revenue (2021-2032)
  8. 7.2.2 North America Pyrazinamide Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pyrazinamide Revenue (2021-2032)
  11. 7.3.2 Europe Pyrazinamide Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pyrazinamide Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pyrazinamide Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pyrazinamide Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pyrazinamide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Beijing Ouhe Technology
  2. 8.1.1 Beijing Ouhe Technology Company Information
  3. 8.1.2 Beijing Ouhe Technology Business Overview
  4. 8.1.3 Beijing Ouhe Technology Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Beijing Ouhe Technology Pyrazinamide Product Portfolio
  6. 8.1.5 Beijing Ouhe Technology Recent Developments
  7. 8.2 Energy Chemical
  8. 8.2.1 Energy Chemical Company Information
  9. 8.2.2 Energy Chemical Business Overview
  10. 8.2.3 Energy Chemical Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Energy Chemical Pyrazinamide Product Portfolio
  12. 8.2.5 Energy Chemical Recent Developments
  13. 8.3 Waterstone Technology
  14. 8.3.1 Waterstone Technology Company Information
  15. 8.3.2 Waterstone Technology Business Overview
  16. 8.3.3 Waterstone Technology Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Waterstone Technology Pyrazinamide Product Portfolio
  18. 8.3.5 Waterstone Technology Recent Developments
  19. 8.4 Toronto Research Chemicals
  20. 8.4.1 Toronto Research Chemicals Company Information
  21. 8.4.2 Toronto Research Chemicals Business Overview
  22. 8.4.3 Toronto Research Chemicals Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Toronto Research Chemicals Pyrazinamide Product Portfolio
  24. 8.4.5 Toronto Research Chemicals Recent Developments
  25. 8.5 TCI
  26. 8.5.1 TCI Company Information
  27. 8.5.2 TCI Business Overview
  28. 8.5.3 TCI Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 TCI Pyrazinamide Product Portfolio
  30. 8.5.5 TCI Recent Developments
  31. 8.6 Pure Chemistry Scientific
  32. 8.6.1 Pure Chemistry Scientific Company Information
  33. 8.6.2 Pure Chemistry Scientific Business Overview
  34. 8.6.3 Pure Chemistry Scientific Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pure Chemistry Scientific Pyrazinamide Product Portfolio
  36. 8.6.5 Pure Chemistry Scientific Recent Developments
  37. 8.7 Meryer (Shanghai) Chemical Technology
  38. 8.7.1 Meryer (Shanghai) Chemical Technology Company Information
  39. 8.7.2 Meryer (Shanghai) Chemical Technology Business Overview
  40. 8.7.3 Meryer (Shanghai) Chemical Technology Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Meryer (Shanghai) Chemical Technology Pyrazinamide Product Portfolio
  42. 8.7.5 Meryer (Shanghai) Chemical Technology Recent Developments
  43. 8.8 LGM Pharma
  44. 8.8.1 LGM Pharma Company Information
  45. 8.8.2 LGM Pharma Business Overview
  46. 8.8.3 LGM Pharma Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LGM Pharma Pyrazinamide Product Portfolio
  48. 8.8.5 LGM Pharma Recent Developments
  49. 8.9 J & K SCIENTIFIC
  50. 8.9.1 J & K SCIENTIFIC Company Information
  51. 8.9.2 J & K SCIENTIFIC Business Overview
  52. 8.9.3 J & K SCIENTIFIC Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 J & K SCIENTIFIC Pyrazinamide Product Portfolio
  54. 8.9.5 J & K SCIENTIFIC Recent Developments
  55. 8.10 HBCChem
  56. 8.10.1 HBCChem Company Information
  57. 8.10.2 HBCChem Business Overview
  58. 8.10.3 HBCChem Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 HBCChem Pyrazinamide Product Portfolio
  60. 8.10.5 HBCChem Recent Developments
  61. 8.11 EDQM
  62. 8.11.1 EDQM Company Information
  63. 8.11.2 EDQM Business Overview
  64. 8.11.3 EDQM Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 EDQM Pyrazinamide Product Portfolio
  66. 8.11.5 EDQM Recent Developments
  67. 8.12 City Chemical
  68. 8.12.1 City Chemical Company Information
  69. 8.12.2 City Chemical Business Overview
  70. 8.12.3 City Chemical Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 City Chemical Pyrazinamide Product Portfolio
  72. 8.12.5 City Chemical Recent Developments
  73. 8.13 AlliChem
  74. 8.13.1 AlliChem Company Information
  75. 8.13.2 AlliChem Business Overview
  76. 8.13.3 AlliChem Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AlliChem Pyrazinamide Product Portfolio
  78. 8.13.5 AlliChem Recent Developments
  79. 8.14 Alfa Chemistry
  80. 8.14.1 Alfa Chemistry Company Information
  81. 8.14.2 Alfa Chemistry Business Overview
  82. 8.14.3 Alfa Chemistry Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Alfa Chemistry Pyrazinamide Product Portfolio
  84. 8.14.5 Alfa Chemistry Recent Developments
  85. 8.15 Acros Organics
  86. 8.15.1 Acros Organics Company Information
  87. 8.15.2 Acros Organics Business Overview
  88. 8.15.3 Acros Organics Pyrazinamide Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Acros Organics Pyrazinamide Product Portfolio
  90. 8.15.5 Acros Organics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pyrazinamide Value Chain Analysis
  2. 9.1.1 Pyrazinamide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pyrazinamide Production Mode & Process
  6. 9.2 Pyrazinamide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pyrazinamide Distributors
  9. 9.2.3 Pyrazinamide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst